Yu Zeng

Tongji University School of Medicine - Department of Pathology

China

SCHOLARLY PAPERS

1

DOWNLOADS

62

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Antitumor Activity of First-Line Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancers: A Large Cohort, Multi-Center, Retrospective Study

Number of pages: 27 Posted: 28 Oct 2020
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Central South University - Department of Medical Oncology, Burning Rock Biotech, Burning Rock Biotech, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Tongji University School of Medicine - Department of Pathology, Department of Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Department of Genetics, School of Life Science, Anhui Medical University, Chinese Academy of Sciences (CAS) - Institute of Basic Medicine and Cancer (IBMC), Department of Radiotherapy; Qilu Hospital of Shandong University, Huazhong University of Science and Technology - Cancer Center, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, First Affiliated Hospital, China Medical University, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Chinese Academy of Sciences (CAS) - Department of Medical Oncology, University of California, Irvine - Chao Family Comprehensive Cancer Center and Central South University - Department of Medical Oncology
Downloads 62 (766,542)

Abstract:

Loading...

ROS1 fusion, ROS1 gene rearrangements, crizotinib, non-CD74 ROS1 fusions, crizotinib resistance mechanism